Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Crossref DOI link: https://doi.org/10.1186/s10194-022-01423-x
Published Online: 2022-05-17
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nahas, Stephanie J.
Naegel, Steffen
Cohen, Joshua M.
Ning, Xiaoping
Janka, Lindsay
Campos, Verena Ramirez
Krasenbaum, Lynda J.
Holle-Lee, Dagny
Kudrow, David
Lampl, Christian
Text and Data Mining valid from 2022-05-17
Version of Record valid from 2022-05-17
Article History
First Online: 17 May 2022